Cytokinetics is a late-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of potential medicines aimed at improving muscle function. The company is particularly active in developing treatments for cardiovascular and neuromuscular diseases, such as heart failure, hypertrophic cardiomyopathy, and other conditions of impaired muscle function. Cytokinetics has a robust pipeline of small molecule muscle activators and inhibitors and is committed to improving patients' lives through its scientific research and development efforts. The company's mission revolves around empowering muscle and thereby empowering lives, with patients being the central focus of its activities. Based in South San Francisco, Cytokinetics has been pioneering the field of muscle biology for over 25 years.
Heart Failure β’ Amyotrophic Lateral Sclerosis β’ Hypertrophic Cardiomyopathy
201 - 500 employees
Founded 1998
𧬠Biotechnology
π Pharmaceuticals
βοΈ Healthcare Insurance
π° $450M Post-IPO Debt on 2022-06
February 19
Join Cytokinetics as a Clinical Scientist to analyze clinical data and collaborate on studies.
πΊπΈ United States β Remote
π° $450M Post-IPO Debt on 2022-06
β° Full Time
π‘ Mid-level
π Senior
π§ͺ Clinical Research
π¦ H1B Visa Sponsor